Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

iQIYI Releases Its XR App for Apple Vision Pro PR Newswire BEIJING , July 1, 2024 /PRNewswire/ -- On June 27, iQIYI, a leading online entertainment service in China , announced the launch of its Apple Vision Pro App, iQIYI XR. As one of the first batch o...

2024-07-01 07:33:00 ET This article first appeared on our U.S. website. We can probably all agree that the world will look different in 2034. However, much will likely remain more or less the same as it is today. For example, I expect Nvidia ( NASDAQ: NVDA ) will...

2024-07-01 07:33:00 ET This article first appeared on our U.S. website. We can probably all agree that the world will look different in 2034. However, much will likely remain more or less the same as it is today. For example, I expect Nvidia ( NASDAQ: NVDA ) will...

2024-07-01 07:33:00 ET This article first appeared on our U.S. website. We can probably all agree that the world will look different in 2034. However, much will likely remain more or less the same as it is today. For example, I expect Nvidia ( NASDAQ: NVDA ) will...

2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations

2024-07-01 07:30:04 ET H.C. Wainwright analyst issues NEUTRAL recommendation for SAVA on July 1, 2024 06:07AM ET. The previous analyst recommendation was Buy. SAVA was trading at $12.35 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...

2024-07-01 07:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for HCAT on July 1, 2024 06:12AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Applications and Grants Priority Review for Crinecerfont for Pediatric and Adult Patients with CAH PR Newswire PDUFA Target Action Dates in Late December 2024 Highly Selective CRF 1 Antagonist is the Potent...

MONTRÉAL, July 01, 2024 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier” or “Company”) today announced that it has reached an agreement to settle the lawsuit titled Antara Capital Master Fund LP, Corbin ERISA Opportunity Fund Ltd. and Corbin Opportunity Fund, L...

Fortune and JFSL remain interested in concluding a transaction under a new arrangement Fortune Minerals Limited (TSX: FT) (OTCQB: FTMDF) (“ Fortune ” or the “ Company ”) ( www.fortuneminerals.com ) announces that the option to purchase the JFSL ...